A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

By Kalviainen R.   Brodie M.J.   Duncan J.   Chadwick D.   Edwards D.   Lyby K.   for the Northern European Tiagabine Study Group  

Epilepsy Research, Vol. 30, Iss. 1, 1998-03 ,pp. : 31-40

Elsevier

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

By Sharief M.   Viteri C.   Ben-Menachem E.   Weber M.   Reife R.   Pledger G.   Karim R.  

Epilepsy Research, Vol. 25, Iss. 3, 1996-11 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

By Palhagen S.   Canger R.   Henriksen O.   van Parys J.A.   Riviere M.-E.   Karolchyk M.A.  

Epilepsy Research, Vol. 43, Iss. 2, 2001-02 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Evaluation of Gabapentin in an Outpatient and Office-based Sample of Epilepsy Patients - Two double-blind, placebo controlled studies

By Harden C.L.   Hosain S.   Nikolov B.   Labar D.R.  

Journal of Epilepsy, Vol. 11, Iss. 3, 1998-05 ,pp. : 130-135

Elsevier

Access to resources Recommend Favorite

Oral Zinc Sulphate Supplementation for Six Months in SCA2 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

By Velázquez-Pérez Luis  

Neurochemical Research, Vol. 36, Iss. 10, 2011-10 ,pp. : 1793-1800

Springer Publishing Company

Access to resources Recommend Favorite